BEQAs

l od Bank External Quality Assessment Scheme

B ° Cyck No: 15

Participanf Name:
Participant Code No.: NBTC0328
. Month: July 2024
)
Samples# 01, 02, 03, O.t & 05- Serum Specimens
I
1---s-·.--,--,->a_r_a_m-et_e_r--..--M-e-tl-10-do_l_og-y-r-:-C-u-to~r=r-,---S-;:;a-m-=p;:lc-- Sample
Sample Sample Sample
No. I Value No.01 No.02 No.04
Equipment 1---.....---·
OD -
Res ult OD Result OD
No.03
Result
--
-OD
Result or J
No.05
Rcs11i1
.-• Used
----.1-------1------
A. HBsAg
- - - - ---- - - -- . - . ·-
I
£L,sA o· oc.,, Q•(\<l N" Q•~O 5'-Jlt O•'OO .,_i(l c•~.:l N~ o•v 0 NR_ I
Anti-HIV 1&2
-- - - ---- - - - -· - - I
I
I
!
I B. 0 ,oa ('J fl r-JR N ((._
O·l.3' 0•0l Q•CC O•00
~-~~:R~l
-) I
----1--------;-------+-----+
~L\SA
--- --- - - ---- ---- ---·
l - I

- C. Anti-HCV
~L\.SA
·---
o •'2-'-\ C Q•C)~ NA.
.
0
,oo\ NP-... (\ •IO<l N fl-
-------
~•~O
-- --
NP-
-- -- -
O•t1-'
I
i Nft.

I
ll). - - Syphilis 0 ,ct\) f'JR ()•Ol~ f'Jfl.. 0 .391 Re.a,~I 0 . ca.1
I
rJ ,z
- L I J__ - I - - -- - .
Samples# 06 c:~ 07- Whole Blood I
- - - - - - - ---- I
I - - -- - - - - - - ~ - - - -- --,
' Sample No.06
·,i ___ s_.__N°_. -- L~aramctcr l\ilcthodology/
~ Equipment Used
-------- - -1r ~ --- -· ----!

E. : Malaria N~-~ 10""'1- ~ •

I E-L\ SA
:- ---~--~----; •1.,arasite · ~
AB_s C_o ,oos) I Pitis ·(_ 0 , 0 l O )
- - - - - - - - - + - · -----

r .;. -- - -- I ::~:~lobin
I
I I , . '
-------- - --·1
I Sample No-08 (Patient) I

/ - - - - - -------1
I

G. Direct Anti-globulin Test (DAT) (Sample No. 08) I Positive / ~ v c I

- - - - - - - - - - - - -1
H. ;\BO Rh (D) ~rouping & Typi,ng Technique ~scd (Sample No. 08) I
I

- - - - - - - - - - ·I'
Scoring System ABO Rh (D) Grouping & Typing
,1

(Tick Appropriately)
--------- -- -

0-4+
-
~ - , 'ritlc tl'ube Column 7··· Colu~11n I rvticro I Othct"
I
l I
(

(Gel) (Bead)
,~>aticnt ldQntitication
___ ·--- -- ------- ---
-· -- Ceil (Forward) Typiug Plasma (Reverse) Group
--- ---- ----
Plate; j
·- ---- l - -
ABO & Rh (1>)
Siwc if~·
I
I
I " Circle as appropriate Circle as appropriate Result I
Anti Anti Anti Anti A 1 Cells B Cells 0 Cells
I.
A B AB* D
- ..- Neg.
- -- -- ... ·-
Neg.( Ncg.__...i (Neg:__) Neg. Neg. Neg.
( .....

l+ l+ I+ l+ l+ l+ )+
As a Patient
I (Sample No: 08)
2+ 2-t 2+ 2+ 2+ 2-t 2+
O+Y(_
3+ 3+ 3+ JI
3 I- 3+ 3·1·

*( •.,n;,·, Rc•d (',.IIs 'i uspCll!IIOII

• & Pl:1sm11) '11
~
41 41- ,f I ( 1i__) ( 1i+)

.
I
I
- ------- ----------------. __ , _ . L _ _

Par,e 1 of 2
 BEQJ\S
Blood Bank External Quality Assessment Scheme
Cycle No: 15
1--;;p~-:-:---~--------= -=~;;:;;8~-----------
articipant Code No.: NBTC032
I. ABO Rh D Grou echni ue Used Sam les No. 09, 10 & 11
Scoring System ABO Rh (D) Grouping & Typing
Tick A
- 4+ Title Tube Column Micro Other
Bead) Plate S ecify
PaJic!!_t ldc~itifi~ation Cell Forw· 1in Plasma cvcrsc Grou ABO&Rh0))-
Circle as a iate Circle as a riate Rcsult
Anti Anti A I Cells B Cells O Cells
A B
As a Donor Unit No-1 Ne.
(Sample No: 09) I+ l+
2+ 2+ 2+ 2+ 2+ 2+ O+k
* (5'1/., Retl Cl'lls Sus11ension & Plasma) 3+ 3+ 3+
4+
Neg.
As a Donor Unit No-2 l+
(Sample No: 10) 2+ 2+
3+ 3+ 3+ 3+ 3+
* (5'1/., Red Cells Suspension & Plasma)
3+

As a Donor Unit No-3

(Sample No: 11) 2+ 2+ 2+ 2+
0-+ve.
3+ 3+ 3+ 3+ 3+ 3+
*(5% Red Cells Suspension & Plasma) 4+ 4+ 4+
Method Used Tube
I Circle

F ==~~~--_-_____ J ._C_om.....:..;.ap:~a~ti=br=il=i.t.........::.:...=..::...=~:,==:=.c.:l=es::....:N:...:..::.o.:....:1:.::22, ~13::.......=&~14.:.L__ _- . - - - - - - I

-.. - ' --~• ~--~ -= -Saline

________,____S_c_Qr!!!J ~ystem ~!~£~- _ _Q_~_~+
\Vith Additive LISS/ Others** Would you transfuse
Sample No of Room Room 37 C IAHG this unit?
I
Donor & Reci ient Temperature Circle

Sample No. (Donor) - 09 1+

2+
1+
2+
l+
2+
l+
2+
✓
Sample No. (Recipient) - 12 NO
3+ 3+ 3+ 3+
4+ 4+ 4+

Sample No. (Donor) -10 1+ ✓s

2+ 21- 2+ 2+ NO
Sample No. (Recipient) - 13
3+ 3+ 3+ 3-1
4+ 4+ 4+ 4+

Sample No. (Donor)-11 1+ l+

2+ 2+ 2+ 2+
Sample No. (Recipient) - 14
3+ 3+ 3+ 3+
- - - - - - - - - - - - - t - - - - - - - - - - - -4+
4+ 4+ 4+
---L-------~-----t------------1
**Specify Other Additive *** Other
-·----:--:--------:::-'----:-----:-::-::---~----:....-- Method
------'-----~---------
Abbreviations Used: I. IAHG- Indirect Anti Human Globulin, 2. LISS- Low Ionic Strength Saline
*Optional Tests: To be performed only if it is your routine practice OR deemed appropriate
Important
• If any of these tests are not being performed please code as NP (Not Participated).
• Send results in format provided with cycle.
• Results received in any format other than the one provided and without the CODE NUMBER will not be included for
analysis.
• Sea eport should reach at BEQAS Office via 'e-mail by 5:00 PM of 10th August 2024.

E-~;il~J~m~~~f ~~SIAAcom ~ ~ ~ \~ •
Signaturc_--1,,,L.._._i\-R-lt}-'\;'"? .>£.----Sc3Mn tMED), OIHBT ___ Datc_1,;
__ ~~~-
M()I/C BloocfBant< Ital
Govt. R08fr~p~~ :i~:.enCOI
RUHS College of Nia \,;at•I0«78
Jaipur (Ra}.) • RMC tfo •